Patient stories

IgG4ward! EuroJAM Session 2: Challenges in the journey to diagnosis with Dr. Emma Culver

Why is IgG4-related disease so difficult to diagnose? In Session 2 of IgG4ward! EuroJAM, Dr. Emma Culver explores the factors that contribute to diagnostic delays and discusses how awareness, education, and collaboration can help improve the diagnostic journey for patients and families.

IgG4ward! EuroJAM Session 1: The history and evolution of IgG4-related disease

The inaugural IgG4ward! EuroJAM opened with a powerful reminder that no one should face IgG4-related disease alone. In Session 1, Dr. John Stone explores the history and evolution of IgG4-RD, tracing the discoveries that led to recognition of the disease and continue to shape research and patient care today.

IgG4ward! EuroJAM: Hope in action

Hope was a theme throughout the IgG4ward! EuroJAM - but not as wishful thinking. Patients, caregivers, researchers, physicians and industry partners came together to share knowledge, build connections and move the conversation around IgG4-related disease forward. Here's a look back at the event and what's coming next.

While rituximab is often seen as a “wonder drug” for IgG4-RD patients, Dr. Michael Bamber, who lives with IgG4-RD, shared a sobering story about his recent episode of sepsis. He was left to wonder, “Could rituximab somehow have played a role?”